ctrl K

Price Alert

Legend Biotech Corporatio... (LEGN)

NASDAQ: LEGN · Real-Time Price · USD

37.47

-0.03 (-0.08%)

At close: Aug 18, 2025, 3:59 PM

37.43

-0.11%

After-hours: Aug 18, 2025, 06:17 PM EDT

Legend Biotech Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	627.24M	285.14M	117M	89.79M
Cost of Revenue	234.58M	144.21M	65.36M	313.35M
Gross Profit	392.66M	140.93M	51.64M	-223.55M
Operating Income	-303.24M	-439.49M	-455.83M	-393.02M
Interest Income	61.2M	54.49M	8.18M	971K
Pretax Income	-158.13M	-520.12M	-445.72M	-386.21M
Net Income	-177.03M	-518.25M	-446.35M	-386.21M
Selling & General & Admin	284.26M	200.93M	174.05M	149.48M
Research & Development	413.54M	382.22M	335.65M	313.35M
Other Expenses	-1.91M	n/a	2.23M	-6.07M
Operating Expenses	695.9M	140.93M	509.7M	462.83M
Interest Expense	21.61M	21.79M	10.8M	900K
Selling & Marketing Expenses	147.48M	94.16M	93.42M	102.54M
Cost & Expenses	930.48M	727.36M	575.06M	462.83M
Income Tax Expense	18.89M	-1.86M	625K	1K
Shares Outstanding (Basic)	91.43M	88.04M	79.52M	70.43M
Shares Outstanding (Diluted)	91.43M	88.04M	79.52M	70.43M
EPS (Basic)	-1.94	-5.88	-5.62	-5.48
EPS (Diluted)	-1.94	-5.88	-5.62	-5.48
EBITDA	-113.16M	-477.87M	-416.54M	-392.38M
EBIT	-136.52M	-498.32M	-434.93M	-406.3M
Depreciation & Amortization	23.36M	20.45M	18.39M	13.92M